Skip to Main Content.
Site navigation
Fidelity.com Home
  • Customer Service
  • Profile
  • Open an Account
  • Virtual Assistant
  • Log In
  • Customer Service
  • Profile
  • Open an Account
  • Virtual Assistant
  • Log Out
  • Accounts & Trade
    • Portfolio Log In Required
    • Portfolio
    • AccountPositions Log In Required
    • AccountPositions
    • Trade Log In Required
    • Trade
    • Trading Dashboard Log In Required
    • Trading Dashboard
    • Active Trader Pro
    • Transfers
    • Cash Management Log In Required
    • Cash Management
    • Bill Pay Log In Required
    • Bill Pay
    • Full View Log In Required
    • Full View
    • Security Settings Log In Required
    • Security Settings
    • Account Features Log In Required
    • Account Features
    • Documents Log In Required
    • Documents
    • Fidelity Alternative Investments Program Log In Required
    • Tax Forms & Information
    • Retirement Distributions Log In Required
    • Fidelity Rewards+registered trademark Log In Required
    • Fidelity Rewards+registered trademark Log In Required
    • New Account Checklist Log In Required
    • Lending Solutions-Line of Credit Log In Required
    • Refer a Friend
  • Planning & Advice
    • What We Offer
    • Build Your Free Plan
    • My Goals
    • Financial Basics
    • Building Savings
    • Robo Investing Plus Advice
    • Wealth Management
    • Find an advisor
    • Retirement
    • Life Events
    • Saving & Investing for a Child
    • Charitable Giving
    • Philanthropic Consulting
    • Life Insurance & Long Term Care Planning
  • News & Research
    • News
    • Wealth Management Insights
    • Watch List Log In Required
    • Quotes
    • Quotes
    • Alerts Log In Required
    • Mutual Funds
    • Stocks
    • Fixed Income, Bonds & CDs
    • ETFs
    • Options
    • Markets & Sectors
    • IPOs
    • Annuities
    • Learning Center
    • Notebook Log In Required
    • Notebook
  • Products
    • Mutual Funds
    • Retirement & IRAs
    • Stocks and Trading
    • Crypto
    • Direct Indexing
    • Fixed Income, Bonds & CDs
    • ETFs
    • Options
    • Sustainable Investing
    • Spending & Saving
    • Managed Accounts
    • 529 College Savings
    • Health Savings Accounts
    • Annuities
    • Life Insurance
  • Why Fidelity
    • The Fidelity Advantage
    • Planning & Advice
    • Trading
    • Straightforward Pricing
    • Insights & Tools
    • Security & Protection
    • FDIC & SIPC Coverage
    • Marketplace Solutions
    • About Fidelity
    • Careers
  • Customer Service
  • Profile
  • Open an Account
  • Virtual Assistant
  • Log In
  • Customer Service
  • Profile
  • Open an Account
  • Virtual Assistant
  • Log Out
You are here:
  • Home
  • Research
  • Markets & Sectors
Content and data provided by various third parties and Fidelity – Terms of Use


Find Symbol
Please use symbol entry at top right of page to search

Markets & Sectors

  • Overview

Markets

  • U.S. Markets
  • U.S. Economic Calendar
    • Global Markets
    • Americas
    • EMEA
    • Asia-Pacific
    • Global Economic Calendar

    U.S. Sectors & Industries

    • Sectors & Industries Overview

    News & Reports

    • U.S. Markets
    • Global Markets
    • Reports Search
    Global Markets News

    Show Search News Articles


    Americas

    EMEA

    OK
    Global Markets News
    /research/markets and sectors

    APEC host Thailand's budding marijuana industry faces backlash

    • print Print |
    • A
    • A
    • A
    • BY Reuters|
    • Asia-Pacific , Thailand |
    • 4:00 AM ET 11/17/2022

    By Chayut Setboonsarng and Panarat Thepgumpanat

    BANGKOK (Reuters) - Near the grand conference halls in central Bangkok where Asian leaders will meet this week, a plethora of marijuana shops - the Thai capital's newest tourist draw - were bustling despite a controversy that threatens the growing sector.

    Since Thailand decriminalised cannabis this year shops selling homegrown and imported strains, pre-rolled joints and gummies sprang up rapidly.

    New cafes with names such as MagicLeaf and High Society are located just minutes from the meetings of the Asia-Pacific Economic Cooperation (APEC) summit.

    But the proliferation of such businesses has sparked a backlash from some politicians and doctors who say the change was pushed through without regulation and are now calling for tougher rules, or even a new ban.

    A cannabis regulation bill to govern cultivation, sale, and consumption has been delayed in parliament, causing confusion over just aspects will be legal.

    "We're in a vacuum," one senator, Somchai Sawangkarn, told a domestic broadcaster on Wednesday, adding that announcements by the health ministry had not curbed recreational use.

    Southeast Asia has strict laws prohibiting the sale and use of most drugs, but Thailand became a major exception in June, when it dropped cannabis from its list of narcotics.

    The move was spearheaded by health minister Anutin Charnvirakul, who framed marijuana as a cash crop for farmers and championed its medical use, but recreational use exploded.

    Authorities later rushed through piecemeal updates to the regulation clarifying that cannabis could not be sold to children or near schools and temples.

    'SUPER HIGH' PROFITS

    Netnapa Singathit had a smoking room for a short while after opening her RG420 cannabis store in central Bangkok, but she switched to serving drinks after authorities banned such rooms.

    She called for regulation that standardises quality, adding, "We are concerned about operators who are not compliant, and customers end up with bad products."

    Recent weeks have brought a wave of news reports about hospitalisations and use by children.

    The president of Thailand's association of forensic physicians, Smith Srisont, petitioned a court last week to re-list it as a narcotic.

    "It was wrong to not have governing laws before unlocking cannabis ... it is not being used medically, but recreationally," he told reporters.

    Yet with major profits to be had, many business owners are relaxed about coming changes. Anutin has ruled out recriminalisation, but supports greater regulation.

    Akira Wongwan, the chief executive of a medical cannabis business, Adam Group, said profit margins for recreational cannabis were "super high".

    The sector could be worth $1.2 billion by 2025, the University of the Thai Chamber of Commerce has estimated.

    "Most people still think at least they can get the profits now, even if regulations change," said Akira.

    (Reporting by Chayut Setboonsarng and Panarat Thepgumpanat; Editing by Poppy McPherson and Clarence Fernandez)

    Copyright © Reuters 2008. All rights reserved. Republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

    More Thailand News

    View more Thailand News

    News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

    PDF’s require Adobe® Reader® and will open in a new window.
    Fidelity Investments

    © 1998-2023 FMR LLC.

    All rights reserved.

    • Terms of Use
    • Privacy
    • Security
    • Site Map